15-38253168-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_152594.3(SPRED1):c.-18G>T variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000952 in 1,575,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00010 ( 0 hom. )
Consequence
SPRED1
NM_152594.3 5_prime_UTR
NM_152594.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.12
Genes affected
SPRED1 (HGNC:20249): (sprouty related EVH1 domain containing 1) The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPRED1 | NM_152594.3 | c.-18G>T | 5_prime_UTR_variant | 1/7 | ENST00000299084.9 | NP_689807.1 | ||
SPRED1 | XM_005254202.4 | c.-18G>T | 5_prime_UTR_variant | 1/8 | XP_005254259.1 | |||
SPRED1 | XM_047432199.1 | c.-181G>T | 5_prime_UTR_variant | 1/9 | XP_047288155.1 | |||
SPRED1 | XM_047432200.1 | c.-145G>T | 5_prime_UTR_variant | 1/8 | XP_047288156.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPRED1 | ENST00000299084.9 | c.-18G>T | 5_prime_UTR_variant | 1/7 | 1 | NM_152594.3 | ENSP00000299084 | P1 | ||
SPRED1 | ENST00000561205.1 | n.321G>T | non_coding_transcript_exon_variant | 1/5 | 5 | |||||
SPRED1 | ENST00000561317.1 | upstream_gene_variant | 4 | ENSP00000453680 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152114Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
6
AN:
152114
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000310 AC: 6AN: 193592Hom.: 0 AF XY: 0.0000485 AC XY: 5AN XY: 103184
GnomAD3 exomes
AF:
AC:
6
AN:
193592
Hom.:
AF XY:
AC XY:
5
AN XY:
103184
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000101 AC: 144AN: 1423594Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 75AN XY: 704406
GnomAD4 exome
AF:
AC:
144
AN:
1423594
Hom.:
Cov.:
31
AF XY:
AC XY:
75
AN XY:
704406
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152114Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74296
GnomAD4 genome
AF:
AC:
6
AN:
152114
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 18, 2018 | The c.-18 G>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant is not observed in large population cohorts (Lek et al., 2016). The nucleotide substitution occurs at a position that is conserved across species. However, to our knowledge, no regulatory pathogenic variants have been reported in the SPRED1 gene. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at